Short Interest in Gyrodyne , LLC (NASDAQ:GYRO) Increases By 400.0%

Posted by Brenda Bartman on Jun 27th, 2026

Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 805 shares, a growth of 400.0% from the May 31st total of 161 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 2,212 shares, the short-interest ratio is currently 0.4 days.

Hedge Funds Weigh In On Gyrodyne

Several institutional investors and hedge funds have recently added to or reduced their stakes in GYRO. Bulldog Investors LLP purchased a new position in Gyrodyne during the 3rd quarter valued at about $601,000. Teton Advisors LLC bought a new stake in Gyrodyne during the third quarter worth about $177,000. Susquehanna International Group LLP purchased a new stake in Gyrodyne in the third quarter worth about $142,000. Finally, Advisory Services Network LLC bought a new position in shares of Gyrodyne during the third quarter valued at approximately $77,000. Hedge funds and other institutional investors own 71.36% of the company’s stock.

Gyrodyne Stock Performance

Shares of NASDAQ:GYRO traded down $0.00 during midday trading on Friday, hitting $6.13. 139 shares of the stock traded hands, compared to its average volume of 1,640. The business’s 50 day moving average is $6.95 and its two-hundred day moving average is $8.10. Gyrodyne has a one year low of $6.00 and a one year high of $12.00.

Gyrodyne Company Profile

(Get Free Report)

Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.

The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.